BioRabbit RHDV 1,2, Suspension for injection
BioRabbit RHDV 1,2, Suspension for injection
Authorised
- Rabbit haemorrhagic disease virus, type 1, strain Borohradek, Inactivated
- Rabbit haemorrhagic disease virus, type 2, strain Ceska Lipa, Inactivated
Product identification
Medicine name:
BioRabbit RHDV 1,2, Suspension for injection
BioRabbit RHDV 1, 2, suspenzija za injekciju, za kuniće
Active substance:
- Rabbit haemorrhagic disease virus, type 1, strain Borohradek, Inactivated
- Rabbit haemorrhagic disease virus, type 2, strain Ceska Lipa, Inactivated
Target species:
-
Rabbit
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Rabbit haemorrhagic disease virus, type 1, strain Borohradek, Inactivated60.00/haemagglutination inhibiting unit(s)1.00Dose
-
Rabbit haemorrhagic disease virus, type 2, strain Ceska Lipa, Inactivated80.00/haemagglutination inhibiting unit(s)1.00Dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Rabbit
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI08AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Croatia
Package description:
- Plastic Vial 10 x 20.0 Dose
- Plastic Vial 10 x 10.0 Dose
- Plastic Vial 1 x 20.0 Dose
- Plastic Vial 1 x 10.0 Dose
- Glass Vial 10 x 20.0 Dose
- Glass Vial 10 x 10.0 Dose
- Glass Vial 10 x 1.0 Dose
- Glass Vial 1 x 20.0 Dose
- Glass Vial 1 x 10.0 Dose
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - known active substance (Article 8 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
- UP/I-322-05/23-01/358
Date of authorisation status change:
Reference member state:
-
Czechia
Procedure number:
- CZ/V/0180/001
Concerned member states:
-
Bulgaria
-
Croatia
-
Greece
-
Hungary
-
Latvia
-
Lithuania
-
Poland
-
Romania
-
Slovakia
-
Slovenia
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Croatian (PDF)
Published on: 20/06/2023
Updated on: 26/06/2023